| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/05/2001 | US6242473 Administering histamine |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242467 Compounds |
| 06/05/2001 | US6242459 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242434 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders. |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | US6242419 Genes encoding proteins expressed in lymph node stromal cells from flaky skin (fsn-/-) mice and their use in therapy. |
| 06/05/2001 | US6242415 Mediation of cytokines by melanin |
| 06/05/2001 | US6242255 Protein which induces interferon-gamma production by immunocompetent cell |
| 06/05/2001 | US6242250 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6242229 Topically applying composition including clarified and stabilized culture medium from non-photosynthetic filamentous bacterium to skin, scalp, or mucous membranes; reduces or delays aging of skin |
| 06/05/2001 | US6242213 Nucleotide sequences coding preferential polypeptide for use in controlling immune response |
| 06/05/2001 | US6242179 Nucleotide sequences coding eukaryotic hydrolase; for the diagnosis, prevention, and treatment of immune defects and cancers; anticarcinogenic agents |
| 06/05/2001 | US6241985 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 06/05/2001 | CA2112408C Monoclonal antibody to lymphocyte-associated cell surface protein |
| 06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
| 06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038397A1 N-alkylated peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038393A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 05/31/2001 | WO2001038389A1 A new polypeptide-ribosomal protein l14.22 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038385A1 A new polypeptide-human phosphatase 79 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038379A1 A new polypeptide-human ribosomal protein l23 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038378A1 A new polypeptide-zinc finger protein 69 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038376A1 A new polypeptide-zinc finger protein 46 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038375A1 A new polypeptide-zinc finger protein 58 and the polynucleotide encoding it |
| 05/31/2001 | WO2001038355A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 05/31/2001 | WO2001038332A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038320A1 Vitamin d analogues |
| 05/31/2001 | WO2001038315A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |
| 05/31/2001 | WO2001038304A1 Heterocyclic ketone and thioester compounds and uses |
| 05/31/2001 | WO2001038303A2 Vitamin d analogues |
| 05/31/2001 | WO2001038288A1 Nervonic acid derivatives, their preparation and use |
| 05/31/2001 | WO2001037890A1 A propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 05/31/2001 | WO2001037870A1 Treatment of autoimmune diseases by an agonistic cd40-binding protein |
| 05/31/2001 | WO2001037869A1 Vaccine compositions |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037865A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | WO2001037860A1 Method of inducing immune tolerance |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037847A2 Nontoxic vernix compositions and method of producing |
| 05/31/2001 | WO2001037844A1 Immuno-active, anti-cancer and pharmacologically active polysaccharide compounds and pharmaceutical compositions containing the polysaccharide compounds |
| 05/31/2001 | WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001037823A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 05/31/2001 | WO2001037820A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001009186A3 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000071140A3 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/31/2001 | WO2000066098A3 Vitamin d derivatives for the treatment of systemic lupus erythematosus |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000047194A9 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO2000009512A3 Bipyridine manganese complexes |
| 05/31/2001 | WO1999062923A3 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 05/31/2001 | US20010002398 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 05/31/2001 | US20010002397 24-Hydroxyvitamin D, analogs and uses thereof |
| 05/31/2001 | DE19952509A1 Polyclonal antiserum against human leucocyte antigen-G, useful for predicting success of in vitro fertilization and for prognosis of melanoma |
| 05/31/2001 | CA2762106A1 Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 05/31/2001 | CA2706113A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | CA2429394A1 Method of inducing immune tolerance |
| 05/31/2001 | CA2394803A1 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392225A1 Novel il-8 receptor antagonists |
| 05/31/2001 | CA2392019A1 Method of forming a peptide-receptor complex with zsig33 |
| 05/31/2001 | CA2391575A1 Heterocyclic ketone and thioester compounds and uses |
| 05/31/2001 | CA2391499A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | CA2390767A1 Nontoxic vernix compositions and method of producing |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2386955A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/31/2001 | CA2386893A1 N-alkylated peptides having antiangiogenic activity |
| 05/30/2001 | EP1103559A1 Autoimmune nucleosides |
| 05/30/2001 | EP1103553A2 Substituted heterocyclic derivatives |
| 05/30/2001 | EP1103272A2 Modulation of TGF-beta by proteolytic enzymes |
| 05/30/2001 | EP1103270A1 Method for treating endotoxic shock and inflammatory and autoimmune diseases in mammals |
| 05/30/2001 | EP1103265A1 T-cells specific for polymorphic proteins on malignant cells |
| 05/30/2001 | EP1102848A2 Molecules designated ldcam |
| 05/30/2001 | EP1102761A2 Cyclopentabenzofuran derivatives and their use |
| 05/30/2001 | EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
| 05/30/2001 | EP1102600A2 Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent |
| 05/30/2001 | EP1102596A1 Peptide antagonists of zonulin and methods for use of the same |
| 05/30/2001 | EP1102579A1 Medicinal aerosol formulations |
| 05/30/2001 | EP1102535A2 Compounds and methods |
| 05/30/2001 | EP0687176B1 Use of riluzole for treating aids-related neural disorders |
| 05/30/2001 | EP0656778B1 Enantiomerically pure beta-d-dioxolane-nucleosides |
| 05/30/2001 | CN1297484A Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |